FDA NDC Directory · JSON-LD · Markdown

FLOLAN

NDC 0173-0519 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameepoprostenol sodium
Labeler / ManufacturerGlaxoSmithKline LLC
Marketing categoryNew Drug Application (innovator) · App NDA020444
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsEPOPROSTENOL SODIUM (1.5 mg/1)
Marketing started19951208
Marketing ended20260531
Package count1

External sources

Source: openFDA. Public-domain (CC0).